Literature DB >> 18486619

Technologies for ablation of hepatocellular carcinoma.

Matthew R Callstrom1, J William Charboneau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18486619     DOI： 10.1053/j.gastro.2008.05.022

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

Review 1.  Therapeutic options for intermediate-advanced hepatocellular carcinoma.

Authors:  Zong-Ming Zhang; Jin-Xing Guo; Zi-Chao Zhang; Nan Jiang; Zhen-Ya Zhang; Li-Jie Pan
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

2.  Estimated effective dose of CT-guided percutaneous cryoablation of liver tumors.

Authors:  Byung Kwan Park; Paul R Morrison; Servet Tatli; Usha Govindarajulu; Kemal Tuncali; Phil Judy; Paul B Shyn; Stuart G Silverman
Journal:  Eur J Radiol       Date:  2011-06-08       Impact factor: 3.528

3.  A multidisciplinary approach to the management of hepatocellular carcinoma.

Authors:  Robert G Gish; Jorge A Marrero; Al B Benson
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-03

4.  Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma.

Authors:  Yang Guo; Yue Zhang; Rachel Klein; Grace M Nijm; Alan V Sahakian; Reed A Omary; Guang-Yu Yang; Andrew C Larson
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

5.  Radiofrequency ablation during continuous saline infusion can extend ablation margins.

Authors:  Toru Ishikawa; Tomoyuki Kubota; Ryoko Horigome; Naruhiro Kimura; Hiroki Honda; Akito Iwanaga; Keiichi Seki; Terasu Honma; Toshiaki Yoshida
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

6.  Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma.

Authors:  Ke-Cheng Xu; Li-Zhi Niu; Qiang Zhou; Yi-Ze Hu; De-Hong Guo; Zheng-Ping Liu; Bing Lan; Feng Mu; Ying-Fei Li; Jian-Sheng Zuo
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

7.  Design and validation of a thermoreversible material for percutaneous tissue hydrodissection.

Authors:  Alexander Johnson; Anthony Sprangers; Patrick Cassidy; Sean Heyrman; J Louis Hinshaw; Meghan Lubner; John Puccinelli; Chris Brace
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2013-11       Impact factor: 3.368

8.  High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma.

Authors:  Yong-Ping Yang; Jian-Hui Qu; Xiu-Juan Chang; Yin-Ying Lu; Wen-Lin Bai; Zheng Dong; Hong Wang; Lin-Jing An; Zhong-Xian Xu; Chun-Ping Wang; Zhen Zeng; Ke-Qin Hu
Journal:  J Transl Med       Date:  2013-02-15       Impact factor: 5.531

Review 9.  Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria.

Authors:  Yanzhao Zhou; Yi Yang; Bingyan Zhou; Zhengzheng Wang; Ruili Zhu; Xun Chen; Jingzhong Ouyang; Qingjun Li; Jinxue Zhou
Journal:  J Hepatocell Carcinoma       Date:  2021-06-21

10.  Thoracic paravertebral block for the anesthetic management of percutaneous radiofrequency ablation of liver tumors.

Authors:  Mohamed M Abu Elyazed; Mohammad A Abdullah
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.